BioWorld MedTech

Aug. 20, 2014

Financings: HQC closes debut fund at $110M to invest in healthcare sectors

HealthQuest Capital (HQC; Menlo Park, California), a new fund sponsored by Sofinnova Ventures, reported the closing of its debut fund at the hard cap of $110 million and in excess of the initial fund target of $50 million. Read More

Nasal brush test could safely diagnose early prion infection in patients

Medtronic sees profit decline, improvement in sales for 1Q14

Protectionist policy being pursued: China to promote domestic devices among its top hospital facilities

HIT Bits: Firm shows how crucial EMRs are in the big data revolution

Agreements/contracts: Cytori and BARDA continue cell development for thermal burns

Daily M&A: LeMaitre Vascular acquires Xenotis for $7.7 million

Product briefs

People in Places

MDD's Oncology Extra

Today's news in brief

BioWorld

BioWorld briefs for Feb. 9, 2025.

MJFF grant supports Bexorg’s translational biomarker work

BioWorld Science

Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...

KLF15 shows potential as marker, target for cholangiocarcinoma

BioWorld Science

Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...

Illustration of SCAN in Parkinson’s vs healthy subcortex

SCAN is core circuit affected in Parkinson’s disease

BioWorld Science

Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...

Astellas’ ASP-2246 shows promise in stroke management

BioWorld Science

Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...